- Use of NeoImmuneTech.com (“our Site”)
- Information for EU residents participating in our studies
Use of NeoImmuneTech.com (“our Site”)
Currently, we do not use our Site to collect your personal information beyond the information you provide through our Contact Us page
. This may include your name, phone number, and email address. We use this information to respond to your inquiries. Any changes to this practice will be reflected in this policy.
Privacy policies of other websites
Our Site may contain links to other websites. This policy applies only to our Site. NIT is not responsible for the privacy and data collection practices of other websites.
Information for EU residents participating in our studies
NIT is the data controller for personal data collected from those participating in the study entitled “A Multicenter, Open-label, Phase II Study of NT-I7
in Combination with Nivolumab in Subjects with Relapsed/Refractory Gastric or Gastro-Esophageal Junction or Esophageal Adenocarcinoma who Progressed on or Intolerant to 2 or more Prior Lines of Systemic Therapy,” Protocol No. NIT-109.
If you are participating in this study and would like information about your data protection/privacy rights, please contact our Data Protection Officer, Project Consulting Group, at email@example.com